Values First Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$460K Buy
2025
Q1
$481K Buy
2024
Q4
$607K Buy
2024
Q3
$397K Sell
2024
Q2
$463K Sell
2024
Q1
$619K Buy
2023
Q4
$584K Buy
2023
Q3
$406K Sell
2023
Q2
$399K Buy
2023
Q1
$202K Buy